Trademark owner · USPTO register · rebuilt nightly

Amgen Inc.

152 live US trademarks, filing since 1987. 26 new applications filed this year.

Live marks
152
registered + pending
Registered
79
on the Principal Register
Pending
73
9 open to opposition
Filed in 2026
26
6 intent to use
Classes used
14
of 45 Nice classes
First filing
1987
39 years on the register
At a glanceplain-language reads of the register
Mostly pharmaceuticals: 101 of 152 live marks are in Class 5. Medical & beauty services (Class 44) is next with 26.
Filing faster than usual: 26 applications so far in 2026 against a yearly average of 8.8.
New products ahead: 6 of the 26 filings this year are intent-to-use applications, meaning the goods are not yet on sale.
9 marks are open to opposition now; the windows close between Oct 29 and Nov 5.
8 registrations have a maintenance filing due in the next 12 months, 7 already in the grace period.
Filing activityapplications per year, by filing date
0 29 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 26 so far

Marks held on the register, by filing date. 2026 is year to date.

Portfolio by classlive marks · rank among filers in that class

A multi-class mark counts once per class. Rank shown where the owner is in the class's top 50.

Latest activity

What Amgen Inc. filed most recently.

MarkClassFiledBasisStatusSerial
IMDELLTRA QX 5 Sep 28, 2026 — pending 50133455
IMDELLTRA GO 5 Sep 28, 2026 — pending 50133460
NIVIMRI 5 Sep 25, 2026 — pending 50130171
XOMIVI 5 Sep 25, 2026 — pending 50130174
XAMNIV 5 Sep 25, 2026 — pending 50130163
ADNOPTI 5 Sep 25, 2026 — pending 50130179
FLYTOVI 5 Sep 15, 2026 — pending 50108635
DRUMLYF 5 Sep 9, 2026 — pending 50098730
STEDTUITY 5 Sep 9, 2026 — pending 50098733
DBITE 5, 9, 42 Jun 15, 2026 — pending 99885409
Open to opposition now30-day windows from publication
AWESMARI · Cl. 5 · published Sep 29
closes Oct 29
JOUVARI · Cl. 5 · published Sep 29
closes Oct 29
BYSTEAPIX · Cl. 5 · published Sep 29
closes Oct 29
BYSTEAP · Cl. 5 · published Sep 29
closes Oct 29
XALREVV · Cl. 5 · published Sep 29
closes Oct 29
XALBREGO · Cl. 5 · published Sep 29
closes Oct 29
LONTUJI · Cl. 5 · published Sep 29
closes Oct 29
JOVIYON · Cl. 5 · published Sep 29
closes Oct 29
LISTEN TO YOUR HEART · Cl. 44 · published Oct 6
closes Nov 5

Anyone who believes they would be harmed by registration can oppose during this window.

Recently registeredlast 12 months
FRACTURE CARE GAP PRIORITIZING OSTEOPOROSIS CARE · Cl. 41, 44 · Reg. 8,474,585
Sep 29, 2026
MARITIDE · Cl. 5 · Reg. 8,393,460
Aug 11, 2026
AMGEN ECOVATION · Cl. 42 · Reg. 8,157,104
Mar 3, 2026

Registration starts the maintenance clock: a Section 8 declaration is due between years 5 and 6.

Maintenance windows aheadnext 12 months · from registration dates
MYELOMA MVP · Reg. 6,048,256 · registered May 2020
Section 8 declaration (years 5–6) · in grace period until Nov 5, 2026
May 5, 2025 → May 5, 2026
AIMOVIG ALLY · Reg. 6,064,730 · registered May 2020
Section 8 declaration (years 5–6) · in grace period until Nov 26, 2026
May 26, 2025 → May 26, 2026
AMGEN · Reg. 6,080,333 · registered Jun 2020
Section 8 declaration (years 5–6) · in grace period until Dec 16, 2026
Jun 16, 2025 → Jun 16, 2026
EVENITY · Reg. 6,134,530 · registered Aug 2020
Section 8 declaration (years 5–6) · in grace period until Feb 25, 2027
Aug 25, 2025 → Aug 25, 2026
HEART FAILURE LINK · Reg. 6,134,580 · registered Aug 2020
Section 8 declaration (years 5–6) · in grace period until Feb 25, 2027
Aug 25, 2025 → Aug 25, 2026
AVSOLA · Reg. 6,142,338 · registered Sep 2020
Section 8 declaration (years 5–6) · in grace period until Mar 1, 2027
Sep 1, 2025 → Sep 1, 2026
LIPID LINK · Reg. 6,148,511 · registered Sep 2020
Section 8 declaration (years 5–6) · in grace period until Mar 8, 2027
Sep 8, 2025 → Sep 8, 2026
PUSHTRONEX · Reg. 5,075,206 · registered Nov 2016
Section 8 & 9 renewal (year 10)
Nov 1, 2025 → Nov 1, 2026

A filing missed by the due date enters a six-month grace period, then the registration cancels.

Other large filers in Class 5Full ranking →
Common questions

About Amgen Inc. trademarks.

How many trademarks does Amgen Inc. have?

152 live US trademarks as of October 23, 2026: 79 registered and 73 pending applications. 26 were filed in 2026 so far.

What does Amgen Inc. sell, according to its trademarks?

Mostly pharmaceuticals (Class 5, 101 live marks). Also medical & beauty services (Class 44) and science & technology (saas) (Class 42).

Who owns the EPOGEN trademark?

EPOGEN is owned by Amgen Inc.. It was registered on June 13, 1989 (Reg. No. 1543197) and is live. The same owner holds 151 other live US marks.

When did Amgen Inc. first file a trademark?

Its oldest live US filing dates from 1987: EPOGEN, filed December 7, 1987.

Know the morning after Amgen Inc. files.

Watch this company in Thorgate and get an alert for every new application, registration, publication and lapse, with the opposition deadline already worked out. Or monitor your own marks for conflicts with theirs.

Data: USPTO trademark bulk files, processed nightly by Thorgate. Last rebuilt October 23, 2026. Counts cover the US federal register only, not state or foreign marks. Owner names are shown as recorded by the USPTO. This page reports public-record facts and dates and is not legal advice. For the official record of any mark, follow its serial number to USPTO TSDR.